AN0025 and Chemoradiotherapy Combination in Esophageal Cancer

NCT05191667 · clinicaltrials.gov ↗
PHASE1
Phase
SUSPENDED
Status
32
Enrollment
INDUSTRY
Sponsor class

Stopped The study is not stopped but the enrollment is suspended until a further decision from sponsor.

Conditions

Interventions

Sponsor

Adlai Nortye Biopharma Co., Ltd.